Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-585724
Filing Date
2016-05-10
Accepted
2016-05-10 16:56:12
Documents
81
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d127798d10q.htm 10-Q 533212
2 EX-31.1 d127798dex311.htm EX-31.1 9037
3 EX-31.2 d127798dex312.htm EX-31.2 8998
4 EX-32.1 d127798dex321.htm EX-32.1 3664
5 EX-32.2 d127798dex322.htm EX-32.2 3626
12 GRAPHIC g127798g0429233126492.jpg GRAPHIC 2478
  Complete submission text file 0001193125-16-585724.txt   4737853

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mslp-20160331.xml EX-101.INS 729053
7 XBRL TAXONOMY EXTENSION SCHEMA mslp-20160331.xsd EX-101.SCH 62815
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mslp-20160331_cal.xml EX-101.CAL 97841
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mslp-20160331_def.xml EX-101.DEF 276531
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mslp-20160331_lab.xml EX-101.LAB 520370
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mslp-20160331_pre.xml EX-101.PRE 398592
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

EIN.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53166 | Film No.: 161636549
SIC: 2834 Pharmaceutical Preparations